Human Cloning Isn’t Monkey Business
By Osagie K. Obasogie,
Genetic Crossroads
| 11. 29. 2007
Rarely have science, politics, and international diplomacy converged as intensely as they have over the past few days.
Researchers at the Oregon National Primate Research Center have accomplished what some scientists equate with breaking the sound barrier: creating cloned embryos from an adult monkey and isolating its stem cells. Since monkeys are humans' closest relatives and embryonic stem cells might treat devastating injuries and diseases, this research has invigorated prospects for developing patient-specific embryonic stem cells for humans by copying the Oregon researchers' new approach. After all, monkey see, monkey do.
Yet another level of intrigue comes from the fact that cloning an embryo to obtain stem cells involves the same underlying process as cloning an embryo to create a living, breathing clone: taking the nucleus from a body cell, sticking it into an egg, and triggering its early development. Research cloning involves stopping this development after a few days to cull the early embryos' stem cells; reproductive cloning entails placing the developing embryo into a surrogate until the clone is born.
Scientists have not yet created a living cloned...
Related Articles
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
